European School of Oncology

Online educational resources at

www.e-eso.netJoin live and interact!from 18:15 to 19:00 hrs CET

12:15 pm Boston, New York

13:15 Buenos Aires, Sao Paulo

17:15 London, Dublin, Lisbon

18:15 Brussels, Paris, Madrid, Milan,

Prague, Warsaw, Johannesburg

19:15 Athens, Tel Aviv, Cairo

20:15 Moscow

e-oncoreview OR15

17 January 2012

18:15-19:00 cET

Implications of a multigene assay for

DcIS on current treatment patterns

Expert: William Wood, Emory University Hospital, Atlanta, GA, USA

Discussant: Nigel Bundred, University Hospital of South Manchester,

Manchester, United Kingdom

e-oncoreview organised

in collaboration with

Card_Genomic (24 Nov)_2 pages_Layout 1 2011/11/30 16:05 Pagina 2

✔ Your weekly/monthly appointment with education

✔ Do not miss live interaction with Expert and Discussant

✔ Every Thursday of each week and first Tuesday of each month,

at the same time

✔ In collaboration with Nature Reviews Clinical Oncology and

Critical Reviews in Oncology Hematology

✔ With and without commercial sponsorship

✔ View six months of recorded sessions

✔ CME and ESMO-MORA accreditation for ESO

organised sessions

✔ Mastermind Participant quiz

IMplIcATIONS OF A MUlTIgENE ASSAy FOR DcIS ONcURRENT TREATMENT pATTERNS

e-oncoreview OR15 - 17 January 201218:15-19:00 CET (12.15/13.00 EST – 17.15/18.00 GMT)

Expert:

William Wood, Emory University Hospital, Atlanta, GA, USA

Discussant:

Nigel Bundred, University Hospital of South Manchester, Manchester, United Kingdom

The introduction of genomic classifiers for ER+ invasive breast cancer have helped clarify which patients

may benefit from chemotherapy.

Now with the introduction of a genomic assay for DCIS, we should consider how this assay will be

integrated with existing risk assessment tools for DCIS and ultimately treatment decisions. This session

will review the existing markers used for DCIS and how the added information from a genomic classifier

predicting the individual risk of local recurrence may be relevant for treatment decisions.

Participants are invited to attend the live session on 17 January 2012 from 18.15 to 19.00 CET or the

recorded session that will be available after 24 hours.

In both modes, attendants participate in remote, without webcam and without appearing in the system.

Questions can be sent in advance to the Discussant who will discuss them with the Expert and consider

to cover them during the live presentation. During the live session, participants have the opportunity to

submit text questions and comments that are received by the Discussant who puts them to the Expert.

Questions submitted during the live session are answered to during the session directly!

Registration to e-ESO is free of charge but required. Please visit www.e-eso.net and enter your details by

clicking on Register now in the Login Section (left bottom box under the menu). Your registration will be

confirmed automatically by e-mail to the given e-mail address.

FURTHER INFORMATION

AT WWW.E-ESO.NET

live, free and just a click away!

e-eso sessionsweekly e-grandrounds and monthly e-oncoreviews

Card_Genomic (24 Nov)_2 pages_Layout 1 2011/11/30 16:05 Pagina 1